Centaurus Financial, Inc. Horizon Therapeutics Public LTD CO Transaction History

Centaurus Financial, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$96.34 - $112.38 $10,886 - $12,698	-113 Reduced 7.85%	1,327 $136,000
Q1 2023 May 17, 2023	BUY	$107.32 - $113.5 $1,395 - $1,475	13 Added 0.91%	1,440 $157,000
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $89,030 - $162,392	1,427 New	1,427 $162,000
Q2 2022 Aug 02, 2022	SELL	$79.4 - $116.36 $41,288 - $60,507	-520 Reduced 25.38%	1,529 $122,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $4,321 - $5,490	50 Added 2.5%	2,049 $216,000

Q4 2021 Feb 01, 2022	SELL	$98.56 - $119.91 $552,034 - $671,615	-5,601 Reduced 73.7%	1,999 $215,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $5,055 - $6,070	55 Added 0.73%	7,600 $833,000
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $7,934 - $8,824	-92 Reduced 1.2%	7,545 $707,000
Q1 2021 Apr 30, 2021	BUY	$71.83 - $95.48 $39,937 - $53,086	556 Added 7.85%	7,637 $703,000
Q4 2020 Jan 25, 2021	BUY	$67.0 - $84.39 $361,733 - $455,621	5,399 Added 320.99%	7,081 $518,000
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $92,896 - $134,442	1,682 New	1,682 $131,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.